Helping our clients move healthcare forward
Deal Announcement
Leerink Partners Deal Announcement: Structure Therapeutics
Leerink Partners Serves as Joint Placement Agent for Structure Therapeutics’ (Nasdaq: GPCR) $300 Million Private Investment in Public Equity (PIPE)
Published October 02, 2023More Deal Announcements
View all Deal Announcements
Deal Announcement
Leerink Partners Serves as Exclusive Financial Advisor and Placement Agent to Universal DX on its $70 Million Series B Financing and Strategic Collaboration with Quest Diagnostics
December 2023
Deal Announcement
Leerink Partners Serves as Exclusive Financial Advisor to Freeline Therapeutics (Nasdaq: FRLN) on its Going-Private Transaction with Syncona (LON: SYNC)
November 2023
Deal Announcement
Leerink Partners Serves as Exclusive Financial Advisor and Placement Agent for Q32 Bio’s Proposed Merger with Homology Medicines (Nasdaq: FIXX) and Concurrent $42 Million Private Placement
November 2023
Featured Intelligence
View additional intelligenceSee also:
Capital Markets
Growth-oriented companies need an experienced partner with demonstrated capital-raising power
Learn More